Class ITerminatedD-0299-2022
Drug recall · January 5, 2022
Veklury recall
Why: Presence of Particulate Matter: investigation into a customer complaint confirmed the presence of glass particulates.
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
Veklury (remdesivir) for injection, 100 mg/vial, Single-Dose Vial, Rx only, Manufactured for: Gilead Sciences, Inc., Foster City, CA 94404, NDC 61958-2901-2
- Lots / codes
Lots: 2141001-1A, 2141002-1A, Exp. 01/2024
- Quantity
- 53,473 vials
- Company
- Gilead Sciences, Inc., Foster City, CA
- Distribution
- Nationwide in the USA
- Initiated
- December 3, 2021 · Voluntary: Firm initiated
- Classified
- December 28, 2021
- Reported
- January 5, 2022
- Ended
- July 25, 2022
- How notified
- Press Release
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.